# US 2023/0011622 A1 · Methods and compositions for use of mitochondrial therapies to improve female reproductive potential

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0011622 A1
- Document ID: US20230011622A1
- Status: Published application
- Kind: A1
- Application number: 17/801,406
- Filed: 2021-02-22
- Published: 2023-01-12
- Earliest claimed: 2020-02-20
- Assignees: Northeastern University
- Applicants: Northeastern University
- Inventors: Jonathan L. Tilly; Dori Woods
- Web page: https://patentgrep.com/patent/US20230011622A1

## CPC

- C12N 15/873: Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
- A61K 35/54: Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61P 15/08: for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- C12N 5/0609: {Oocytes, oogonia (fertilised oocytes C12N5/0604)}
- C12N 5/0682: {Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells (oocytes C12N5/0609)}
- G01N 33/502: {for testing non-proliferative effects}
- C12N 2500/84: from mammals
- C12N 2502/04: germ cells
- C12N 2502/243: Cells of the female genital tract, non-germinal ovarian cells
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Disclosed are methods for increasing the fertilization rate of an oocyte in a granulosa cell-oocyte complex, and/or the success rate of in-vitro fertilization by using mitochondrial therapies. Also disclosed are methods of identifying compounds for fertility treatment.

## Claims

### Claim 1

A method of increasing the fertilization rate of an oocyte, wherein the oocyte is in a granulosa cell-oocyte complex, the method comprising transferring a composition of mitochondria into the granulosa cell, wherein the transferred mitochondria has a higher mitochondrial membrane potential (MMP) than the mitochondria in the granulosa cell.

### Claim 2 (depends on 1)

The method of claim 1, wherein the transferred mitochondrial is derived from an autologous or allogeneic cell.

### Claim 3 (depends on 2)

The method of claim 2, wherein the autologous or allogeneic cell is an autologous or allogeneic granulosa cell.

### Claim 4 (depends on 2)

The method of claim 2, wherein the autologous or allogeneic cell is an autologous or allogeneic cumulus cell.

### Claim 5 (depends on 1)

The method of claim 1, wherein the transferred mitochondrial is derived from a stem cell or a progenitor cell.

### Claim 6 (depends on 5)

The method of claim 5, wherein the stem cell or the progenitor cell is an embryonic stem cell, induced pluripotent stem cell, bone marrow-derived stem or progenitor cell, blood-derived stem or progenitor cell, mesenchymal stem cell, or germline stem or progenitor cell.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The method of any one of claims 1-6, wherein the mitochondria is prepared using density gradient separation.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6)

The method of any one of claims 1-6, wherein the mitochondria is prepared using differential centrifugation.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6)

The method of any one of claims 1-6, wherein the mitochondria is prepared using flow cytometry.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The method of any one of claims 1-9, wherein the composition of mitochondria comprises at least 50%, at least 70%, or least 90% mitochondria with higher mitochondrial membrane potential (MMP) than the mitochondria in the granulosa cell.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The method of any one of claims 1-10, wherein the mitochondria is transferred ex vivo.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The method of any one of claims 1-10, wherein the mitochondria is transferred in vivo.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The method of any one of claims 1-10, wherein the mitochondria is transferred in vitro.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The method of any one of claims 1-13, wherein the mitochondria is transferred by vesicle-mediated transfer.

### Claim 15 (depends on 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The method of any one of claims 2-13, wherein the mitochondria is transferred by incubating the autologous or allogeneic cell with the granulosa cell-oocyte complex.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The method of any one of claims 1-15, wherein the composition of mitochondria comprises at least 500 mitochondria, at least 2,500 mitochondria, or at least 5,000 mitochondria.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

The method of any one of claims 1-16, wherein the oocyte is from a human subject.

### Claim 18

A method of identifying a compound for fertility treatment, comprising:
(a) contacting the compound and a granulosa cell; wherein the granulosa cell is in a granulosa cell-oocyte complex;
(b) measuring the mitochondrial membrane potential (MMP) of the granulosa cell; and
(c) detecting an increase in the MMP compared to an untreated granulosa cell, thereby identifying the compound for fertility treatment.

### Claim 19

A method of in vitro fertilization, the method comprising incubating a composition of mitochondria with a granulosa cell, wherein the granulosa cell is in a granulosa cell-oocyte complex; and fertilizing the oocyte in vitro to form a zygote, wherein and the incubated mitochondria has a higher mitochondrial membrane potential (MMP) than the mitochondria in the granulosa cell.

### Claim 20 (depends on 19)

The method of claim 19, wherein the incubated mitochondrial is derived from an autologous or allogeneic cell.

### Claim 21 (depends on 20)

The method of claim 20, wherein the autologous or allogeneic cell is an autologous or allogeneic granulosa cell.

### Claim 22 (depends on 20)

The method of claim 20, wherein the autologous or allogeneic cell is an autologous or allogeneic cumulus cell.

### Claim 23 (depends on 19)

The method of claim 19, wherein the incubated mitochondrial is derived from a stem cell or a progenitor cell.

### Claim 24 (depends on 23)

The method of claim 23, wherein the stem cell or the progenitor cell is an embryonic stem cell, induced pluripotent stem cell, bone marrow-derived stem or progenitor cell, blood-derived stem or progenitor cell, mesenchymal stem cell, or germline stem or progenitor cell.

### Claim 25 (depends on 19, 20, 21, 22, 23, 24)

The method of any one of claims 19-24, wherein the mitochondria is prepared using density gradient separation.

### Claim 26 (depends on 19, 20, 21, 22, 23, 24)

The method of any one of claims 19-24, wherein the mitochondria is prepared using differential centrifugation.

### Claim 27 (depends on 19, 20, 21, 22, 23, 24)

The method of any one of claims 19-24, wherein the mitochondria is prepared using flow cytometry.

### Claim 28 (depends on 19, 20, 21, 22, 23, 24, 25, 26, 27)

The method of any one of claims 19-27, wherein the composition of mitochondria comprises at least 50%, at least 70%, or least 90% mitochondria with higher mitochondrial membrane potential (MMP) than the mitochondria in the granulosa cell.

### Claim 29 (depends on 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)

The method of any one of claims 19-28, wherein the mitochondria is transferred to the granulosa cell ex vivo.

### Claim 30 (depends on 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)

The method of any one of claims 19-28, wherein the mitochondria is transferred to the granulosa cell in vivo.

### Claim 31 (depends on 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)

The method of any one of claims 19-28, wherein the mitochondria is transferred to the granulosa cell in vitro.

### Claim 32 (depends on 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)

The method of any one of claims 19-31, wherein the mitochondria is transferred to the granulosa cell by vesicle-mediated transfer.

### Claim 33 (depends on 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)

The method of any one of claims 20-31, wherein the mitochondria is transferred to the granulosa cell by incubating the autologous or allogeneic cell with the granulosa cell-oocyte complex.

### Claim 34 (depends on 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)

The method of any one of claims 19-33, wherein the composition of mitochondria comprises at least 500 mitochondria, at least 2,500 mitochondria, or at least 5,000 mitochondria.

### Claim 35 (depends on 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

The method of any one of claims 19-34, wherein the oocyte is from a human subject.

### Claim 36

A method to promote the growth and maturation of a follicle or an immature oocyte, the method comprising:
incubating a composition of mitochondria with a granulosa cell, wherein the incubated mitochondria has a higher mitochondrial membrane potential (MMP) than the mitochondria in the granulosa cell; and
contacting the granulosa cell with mammalian ovarian tissue, wherein the mammalian ovarian tissue comprises at least one of the follicle and the immature oocyte, and wherein the granulosa cell promotes the growth and maturation of at least one of the follicle and the immature oocyte.

### Claim 37 (depends on 36)

The method of claim 36, wherein the incubated mitochondrial is derived from an autologous or allogeneic cell.

### Claim 38 (depends on 37)

The method of claim 37, wherein the autologous or allogeneic cell is an autologous or allogeneic granulosa cell.

### Claim 39 (depends on 37)

The method of claim 37, wherein the autologous or allogeneic cell is an autologous or allogeneic cumulus cell.

### Claim 40 (depends on 36, 37, 38, 39)

The method of any one of claims 36-39, wherein the mitochondria is prepared using density gradient separation.

### Claim 41 (depends on 36, 37, 38, 39)

The method of any one of claims 36-39, wherein the mitochondria is prepared using differential centrifugation.

### Claim 42 (depends on 36, 37, 38, 39)

The method of any one of claims 36-39, wherein the mitochondria is prepared using flow cytometry.

### Claim 43 (depends on 36, 37, 38, 39, 40, 41, 42)

The method of any one of claims 36-42, wherein the composition of mitochondria comprises at least 50%, at least 70%, or least 90% mitochondria with higher mitochondrial membrane potential (MMP) than the mitochondria in the granulosa cell.

### Claim 44 (depends on 36, 37, 38, 39, 40, 41, 42, 43)

The method of any one of claims 36-43, wherein the mitochondria is transferred to the granulosa cell by vesicle-mediated transfer.

### Claim 45 (depends on 37, 38, 39, 40, 41, 42, 43)

The method of any one of claims 37-43, wherein the mitochondria is transferred to the granulosa cell by incubating the autologous or allogeneic cell with the granulosa cell-oocyte complex.

### Claim 46 (depends on 36, 37, 38, 39, 40, 41, 42, 43, 44, 45)

The method of any one of claims 36-45, wherein the composition of mitochondria comprises at least 500 mitochondria, at least 2,500 mitochondria, or at least 5,000 mitochondria.

### Claim 47 (depends on 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The method of any one of claims 36-46, wherein the mammalian ovarian tissue is from a human subject.

### Claim 48

A method to improve ex vivo generation of a functional oocyte, the method comprising:
incubating a composition of mitochondria with a granulosa cell, wherein the incubated mitochondria has a higher mitochondrial membrane potential (MMP) than the mitochondria in the granulosa cell; and
contacting the granulosa cell with an oocyte, wherein the oocyte is differentiated from a stem or progenitor cell.

### Claim 49 (depends on 48)

The method of claim 48, wherein the incubated mitochondrial is derived from an autologous or allogeneic cell.

### Claim 50 (depends on 49)

The method of claim 49, wherein the autologous or allogeneic cell is an autologous or allogeneic granulosa cell.

### Claim 51 (depends on 49)

The method of claim 49, wherein the autologous or allogeneic cell is an autologous or allogeneic cumulus cell.

### Claim 52 (depends on 48, 49, 50, 51)

The method of any one of claims 48-51, wherein the mitochondria is prepared using density gradient separation.

### Claim 53 (depends on 48, 49, 50, 51)

The method of any one of claims 48-51, wherein the mitochondria is prepared using differential centrifugation.

### Claim 54 (depends on 48, 49, 50, 51)

The method of any one of claims 48-51, wherein the mitochondria is prepared using flow cytometry.

### Claim 55 (depends on 48, 49, 50, 51, 52, 53, 54)

The method of any one of claims 48-54, wherein the composition of mitochondria comprises at least 50%, at least 70%, or least 90% mitochondria with higher mitochondrial membrane potential (MMP) than the mitochondria in the granulosa cell.

### Claim 56 (depends on 48, 49, 50, 51, 52, 53, 54, 55)

The method of any one of claims 48-55, wherein the mitochondria is transferred to the granulosa cell by vesicle-mediated transfer.

### Claim 57 (depends on 49, 50, 51, 52, 53, 54, 55)

The method of any one of claims 49-55, wherein the mitochondria is transferred to the granulosa cell by incubating the autologous or allogeneic cell with the granulosa cell-oocyte complex.

### Claim 58 (depends on 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

The method of any one of claims 48-57, wherein the composition of mitochondria comprises at least 500 mitochondria, at least 2,500 mitochondria, or at least 5,000 mitochondria.

### Claim 59 (depends on 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58)

The method of any one of claims 48-58, wherein the mammalian ovarian tissue is from a human subject.

### Claim 60

A method of increasing the fertilization rate of an oocyte, wherein the oocyte is in a granulosa cell-oocyte complex, the method comprising incubating a cell with the granulosa cell, wherein the cell comprises mitochondria with a higher mitochondrial membrane potential (MMP) than the mitochondria in the granulosa cell.

### Claim 61 (depends on 60)

The method of claim 60, wherein the cell is an autologous or allogeneic cell.

### Claim 62 (depends on 61)

The method of claim 61, wherein the autologous or allogeneic cell is an autologous or allogeneic granulosa cell.

### Claim 63 (depends on 61)

The method of claim 61, wherein the autologous or allogeneic cell is an autologous or allogeneic cumulus cell.

### Claim 64 (depends on 60)

The method of claim 60, wherein the cell is differentiated from a stem cell or a progenitor cell.

### Claim 65 (depends on 64)

The method of claim 64, wherein the stem cell or the progenitor cell is an embryonic stem cell, induced pluripotent stem cell, bone marrow-derived stem or progenitor cell, blood-derived stem or progenitor cell, mesenchymal stem cell, or germline stem or progenitor cell.

### Claim 66 (depends on 60, 61, 62, 63, 64, 65)

The method of any one of claims 60-65, wherein the oocyte is from a human subject.

### Claim 67

A method of in vitro fertilization, the method comprising incubating a cell with a granulosa cell, wherein the granulosa cell is in a granulosa cell-oocyte complex; and fertilizing the oocyte in vitro to form a zygote, wherein the cell comprises mitochondria with a higher mitochondrial membrane potential (MMP) than the mitochondria in the granulosa cell.

### Claim 68 (depends on 67)

The method of claim 67, wherein the cell is an autologous or allogeneic cell.

### Claim 69 (depends on 68)

The method of claim 68, wherein the autologous or allogeneic cell is an autologous or allogeneic granulosa cell.

### Claim 70 (depends on 68)

The method of claim 68, wherein the autologous or allogeneic cell is an autologous or allogeneic cumulus cell.

### Claim 71 (depends on 67)

The method of claim 67, wherein the cell is differentiated from a stem cell or a progenitor cell.

### Claim 72 (depends on 71)

The method of claim 71, wherein the stem cell or the progenitor cell is an embryonic stem cell, induced pluripotent stem cell, bone marrow-derived stem or progenitor cell, blood-derived stem or progenitor cell, mesenchymal stem cell, or germline stem or progenitor cell.

### Claim 73 (depends on 67, 68, 69, 70, 71, 72)

The method of any one of claims 67-72, wherein the oocyte is from a human subject.

### Claim 74

A method to promote the growth and maturation of a follicle or an immature oocyte, the method comprising:
incubating a cell with a granulosa cell, wherein the cell comprises mitochondria with a higher mitochondrial membrane potential (MMP) than the mitochondria in the granulosa cell; and
contacting the granulosa cell with mammalian ovarian tissue, wherein the mammalian ovarian tissue comprises at least one of the follicle and the immature oocyte, and wherein the granulosa cell promotes the growth and maturation of at least one of the follicle and the immature oocyte.

### Claim 75 (depends on 74)

The method of claim 74, wherein the cell is an autologous or allogeneic cell.

### Claim 76 (depends on 75)

The method of claim 75, wherein the autologous or allogeneic cell is an autologous or allogeneic granulosa cell.

### Claim 77 (depends on 75)

The method of claim 75, wherein the autologous or allogeneic cell is an autologous or allogeneic cumulus cell.

### Claim 78 (depends on 74)

The method of claim 74, wherein the cell is differentiated from a stem cell or a progenitor cell.

### Claim 79 (depends on 78)

The method of claim 78, wherein the stem cell or the progenitor cell is an embryonic stem cell, induced pluripotent stem cell, bone marrow-derived stem or progenitor cell, blood-derived stem or progenitor cell, mesenchymal stem cell, or germline stem or progenitor cell.

### Claim 80 (depends on 74, 75, 76, 77, 78, 79)

The method of any one of claims 74-79, wherein the oocyte is from a human subject.

### Claim 81

A method to improve ex vivo generation of a functional oocyte, the method comprising:
incubating a cell with a granulosa cell, wherein the cell comprises mitochondria with a higher mitochondrial membrane potential (MMP) than the mitochondria in the granulosa cell; and
contacting the granulosa cell with an oocyte, wherein the oocyte is differentiated from a stem or progenitor cell.

### Claim 82 (depends on 81)

The method of claim 81, wherein the cell is an autologous or allogeneic cell.

### Claim 83 (depends on 82)

The method of claim 82, wherein the autologous or allogeneic cell is an autologous or allogeneic granulosa cell.

### Claim 84 (depends on 82)

The method of claim 82, wherein the autologous or allogeneic cell is an autologous or allogeneic cumulus cell.

### Claim 85 (depends on 81)

The method of claim 81, wherein the cell is differentiated from a stem cell or a progenitor cell.

### Claim 86 (depends on 85)

The method of claim 85, wherein the stem cell or the progenitor cell is an embryonic stem cell, induced pluripotent stem cell, bone marrow-derived stem or progenitor cell, blood-derived stem or progenitor cell, mesenchymal stem cell, or germline stem or progenitor cell.

### Claim 87 (depends on 81, 82, 83, 84, 85, 86)

The method of any one of claims 81-86, wherein the oocyte is from a human subject.

### Claim 88

A method of identifying a granulosa cell-oocyte complex for fertilization, the method comprising measuring the mitochondrial membrane potential (MMP) of the granulosa cell; and identifying a granulosa cell-oocyte complex with a granulosa cell comprising a majority of mitochondria with a high MMP, thereby identifying the granulosa cell-oocyte complex for fertilization.
